BioSpace News Archive

Arbutus Biopharma Corporation (Nasdaq: ABUS), today announced preliminary data from its on-going Phase 1a/1b clinical trial demonstrating that its next generation capsid inhibitor, AB-836.

As the COVID-19 pandemic consumes the world’s collective focus, patients continue to suffer from a variety of conditions.

Cytokinetics, Incorporated announced that on November 30, 2021 it granted stock options to purchase an aggregate of 143,500 shares of common stock to 9 new employees, whose employment commenced in November 2021, as a material inducement to their employment.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock options to purchase an aggregate of 68,900 shares of Karyopharm’s common stock to 13 newly-hired employees, with a grant date of November 30, 2021.

Spectrum Pharmaceuticals, Inc. announced today that Tom Riga, currently Chief Commercial and Chief Operating Officer, will be the next President and CEO effective December 31, 2021.

Cybin to Present at the Stifel GMP 2 nd Annual Future of Healthcare Conference on December 8, 2021.

Nanomix Corporation today announced the Company has resubmitted an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for its eLab COVID-19 rapid antigen test.

COMPASS Pathways plc today announced further results from its groundbreaking phase IIb clinical trial of COMP360 psilocybin therapy for treatment-resistant depression (TRD).

MeMed, a leader in the emerging field of advanced host-response technologies, today announces positive results from AutoPilot, a prospective, multicenter study, that evaluated performance of MeMed’s test in distinguishing between bacterial and viral infections.

G1 Therapeutics, Inc. today announced that the Company has initiated a Phase 2, single arm, open-label study of trilaciclib in patients with early-stage triple negative breast cancer (TNBC).